Epstein David R
CIK 0001445826
Chief Executive OfficerDirector
Filings
36
Latest Jun 3, 2026
Issuers covered
6
Showing
36 of 36
Page 1
Track record
13 of 17 open-market trades scored (76% price coverage) - 4 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 13 | 77% | +3.0% | +11.8% | +20.3% | -42.7% |
| 90 days | 13 | 54% | -5.7% | +3.8% | +34.0% | -57.2% |
| 180 days | 11 | 36% | -16.3% | -16.7% | +37.1% | -70.7% |
| 365 days | 7 | 29% | -20.3% | -1.9% | +21.8% | -93.0% |
Issuers
Companies where Epstein David R has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TEM | Tempus Ai, Inc. | 16 | Jun 3, 2026 |
| EVLO | Evelo Biosciences, Inc. | 9 | Jun 30, 2022 |
| AXLA | Axcella Health Inc. | 5 | Jun 3, 2022 |
| SGEN | Seagen Inc. | 3 | Dec 15, 2023 |
| RUBY | Rubius Therapeutics, Inc. | 2 | May 13, 2022 |
| SNTI | Senti Biosciences, Inc. | 1 | Jun 10, 2022 |
All filings
36 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|